Frontiers in Psychiatric Treatment: Psychosis Risk

Frontiers in Psychiatric Treatment is a webinar series designed to equip psychiatrists with the latest knowledge about advances in the field through digestible, clinically relevant updates across an array of subspecialties.

On Tuesday, May 31, Cheryl Corcoran, MD, covered recent developments in the treatment of psychosis risk.

Dr. Corcoran is Associate Professor of Psychiatry at Mount Sinai and Director of the Psychosis Risk Program. She specializes in psychotic disorders including their clinical high risk states which has encompassed research on language, symptom and cognitive profiles, risk biomarkers in neuroimaging and physiology, the role of cannabis and stress, stigma, and services. She has two current NIMH R01 awards that assess the brain mechanisms and cognitive correlates of language across stages of psychosis, as analyzed using computers. She is also a co-investigator in the Accelerated Medicines Partnership in Schizophrenia.
Be the first to comment